[Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: upgrade of the guideline, AWMF-Register 021/011].
Cornberg
M
M
Die Institutsangaben sind am Ende des Beitrags gelistet.
Protzer
U
U
Dollinger
M M
MM
Petersen
J
J
Wedemeyer
H
H
Berg
T
T
Jilg
W
W
Erhardt
A
A
Wirth
S
S
Schirmacher
P
P
Fleig
W E
WE
Manns
M P
MP
D000293:Adolescent; D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002353:Carrier State; D002648:Child; D002675:Child, Preschool; D015897:Comorbidity; D024882:Drug Resistance, Viral; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D005260:Female; D006509:Hepatitis B / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control; D017325:Hepatitis B Vaccines / Q000627:therapeutic use; D019694:Hepatitis B, Chronic / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control; D006526:Hepatitis C / Q000175:diagnosis / Q000188:drug therapy; D003699:Hepatitis D / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D016898:Interferon-alpha / Q000009:adverse effects / Q000627:therapeutic use; D016031:Liver Transplantation; D011247:Pregnancy
D000998:Antiviral Agents; D017325:Hepatitis B Vaccines; D016898:Interferon-alpha